These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 8797513)

  • 1. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial.
    Kuller LH; Tracy RP; Shaten J; Meilahn EN
    Am J Epidemiol; 1996 Sep; 144(6):537-47. PubMed ID: 8797513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial.
    Kuller LH; Eichner JE; Orchard TJ; Grandits GA; McCallum L; Tracy RP
    Am J Epidemiol; 1991 Dec; 134(11):1266-77. PubMed ID: 1755441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocyst(e)ine and risk of cardiovascular disease in the multiple risk factor intervention trial.
    Evans RW; Shaten BJ; Hempel JD; Cutler JA; Kuller LH;
    Indian Heart J; 2000; 52(7 Suppl):S44-52. PubMed ID: 11339440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial.
    Evans RW; Shpilberg O; Shaten BJ; Ali S; Kamboh MI; Kuller LH
    J Clin Epidemiol; 2001 Jan; 54(1):51-7. PubMed ID: 11165468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.
    Rosengren A; Wilhelmsen L; Eriksson E; Risberg B; Wedel H
    BMJ; 1990 Dec; 301(6763):1248-51. PubMed ID: 2148699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective association between lipid soluble antioxidants and coronary heart disease in men. The Multiple Risk Factor Intervention Trial.
    Evans RW; Shaten BJ; Day BW; Kuller LH
    Am J Epidemiol; 1998 Jan; 147(2):180-6. PubMed ID: 9457009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESC Population Studies Lecture 1996. Cardiovascular monitoring of a city over 30 years.
    Wilhelmsen L
    Eur Heart J; 1997 Aug; 18(8):1220-30. PubMed ID: 9458414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.
    Karha J; Bavry AA; Rajagopal V; Henderson MR; Ellis SG; Brener SJ
    Am J Cardiol; 2006 Sep; 98(5):616-8. PubMed ID: 16923447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study.
    Boekholdt SM; Peters RJ; Day NE; Luben R; Bingham SA; Wareham NJ; Hack CE; Reitsma PH; Khaw KT
    Am J Med; 2004 Sep; 117(6):390-7. PubMed ID: 15380495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
    Danesh J; Wheeler JG; Hirschfield GM; Eda S; Eiriksdottir G; Rumley A; Lowe GD; Pepys MB; Gudnason V
    N Engl J Med; 2004 Apr; 350(14):1387-97. PubMed ID: 15070788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study.
    van der Meer IM; de Maat MP; Kiliaan AJ; van der Kuip DA; Hofman A; Witteman JC
    Arch Intern Med; 2003 Jun; 163(11):1323-8. PubMed ID: 12796068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for coronary heart disease and acute-phase proteins. A population-based study.
    Danesh J; Muir J; Wong YK; Ward M; Gallimore JR; Pepys MB
    Eur Heart J; 1999 Jul; 20(13):954-9. PubMed ID: 10361047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum total homocysteine and coronary heart disease: prospective study in middle aged men.
    Whincup PH; Refsum H; Perry IJ; Morris R; Walker M; Lennon L; Thomson A; Ueland PM; Ebrahim SB
    Heart; 1999 Oct; 82(4):448-54. PubMed ID: 10490559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen, coronary heart disease and mortality from all causes in smokers and nonsmokers. The study of men born in 1933.
    Rosengren A; Wilhelmsen L
    J Intern Med; 1996 Jun; 239(6):499-507. PubMed ID: 8656143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cystatin-C and development of coronary heart disease: The PRIME Study.
    Luc G; Bard JM; Lesueur C; Arveiler D; Evans A; Amouyel P; Ferrieres J; Juhan-Vague I; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2006 Apr; 185(2):375-80. PubMed ID: 16046222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint effects of C-reactive protein and other risk factors on acute coronary events.
    Kervinen H; Palosuo T; Manninen V; Tenkanen L; Vaarala O; Mänttäri M
    Am Heart J; 2001 Apr; 141(4):580-5. PubMed ID: 11275923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years.
    Krumholz HM; Seeman TE; Merrill SS; Mendes de Leon CF; Vaccarino V; Silverman DI; Tsukahara R; Ostfeld AM; Berkman LF
    JAMA; 1994 Nov; 272(17):1335-40. PubMed ID: 7772105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses.
    Danesh J; Whincup P; Walker M; Lennon L; Thomson A; Appleby P; Gallimore JR; Pepys MB
    BMJ; 2000 Jul; 321(7255):199-204. PubMed ID: 10903648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
    White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
    J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.
    Eldrup N; Kragelund C; Steffensen R; Nordestgaard BG
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):677-83. PubMed ID: 21194909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.